Rheumasense
Rheumasense is a clinical diagnostics company transforming rheumatoid arthritis (RA) care through real-time, machine learning-powered biomarker testing. Leveraging proprietary technology developed with Mayo Clinic, Rheumasense offers a paradigm shift from subjective clinical assessments to molecular detection of disease activity. Their solution utilizes Liquid Chromatography-Mass Spectrometry (LC-MS) and advanced analytics to provide objective, quantitative insights into RA disease activity, enabling timely, personalized treatment adjustments. The company offers an at-home blood collection kit and clinically validated testing, aiming to reduce joint damage, permanent disability, and ineffective treatments for RA patients. Rheumasense is currently developing its technology for clinical studies, with plans for FDA submission and commercialization, and is initiating a seed funding round.
Rheumasense
Rheumasense is a clinical diagnostics company transforming rheumatoid arthritis (RA) care through real-time, machine learning-powered biomarker testing. Leveraging proprietary technology developed with Mayo Clinic, Rheumasense offers a paradigm shift from subjective clinical assessments to molecular detection of disease activity. Their solution utilizes Liquid Chromatography-Mass Spectrometry (LC-MS) and advanced analytics to provide objective, quantitative insights into RA disease activity, enabling timely, personalized treatment adjustments. The company offers an at-home blood collection kit and clinically validated testing, aiming to reduce joint damage, permanent disability, and ineffective treatments for RA patients. Rheumasense is currently developing its technology for clinical studies, with plans for FDA submission and commercialization, and is initiating a seed funding round.